Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity.

Abstract:

BACKGROUND:The main vitamin D source is exposure to ultraviolet radiation, which aggravates cutaneous lupus erythematosus (CLE). OBJECTIVES:The aims of this study were to identify variables associated with lower serum 25-hydroxyvitamin D [25(OH)D] levels in CLE patients and assess the effect of vitamin D restoration on disease severity. METHODS:Vitamin D status in 60 CLE patients and 117 apparently healthy subjects was compared. We recommended oral vitamin D3 to 27 CLE patients. After one year of treatment, changes in disease severity were assessed and compared to 25 untreated CLE patients. Disease severity was measured by the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI), number of exacerbations, duration of active lesions and patient assessment. RESULTS:Presence of CLE raised the odds of having vitamin D deficiency (OR 3.47, 95% CI 1.79-6.69). Increasing age and disease duration were associated with higher odds of having vitamin D deficiency. After a one-year follow-up, disease activity improved in the treatment group (CLASI A 2.7 ± 2.9 vs. 0.9 ± 1.4) (p = 0.003), as confirmed by the patient assessment (p = 0.01). CONCLUSIONS:Vitamin D inadequacy is more prevalent in CLE participants than in healthy controls. Treating vitamin D insufficiency is associated with improved disease severity according to physician and patient assessments.

journal_name

Lupus

journal_title

Lupus

authors

Cutillas-Marco E,Marquina-Vila A,Grant WB,Vilata-Corell JJ,Morales-Suárez-Varela MM

doi

10.1177/0961203314522338

subject

Has Abstract

pub_date

2014-06-01 00:00:00

pages

615-23

issue

7

eissn

0961-2033

issn

1477-0962

pii

0961203314522338

journal_volume

23

pub_type

杂志文章

相关文献

LUPUS文献大全
  • SLEDAI-2K for a 30-day window.

    abstract::The aim of our study was to determine whether the SLEDAI-2K calculated using a timeframe of 30 days prior to a visit for clinical and laboratory variables was equivalent to the prescribed 10-day period. One hundred forty nine consecutive lupus patients seen over 9 weeks at the University of Toronto Lupus Clinic enroll...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309346505

    authors: Touma Z,Urowitz MB,Gladman DD

    更新日期:2010-01-01 00:00:00

  • Innate immunity and atherogenesis.

    abstract::Atherosclerosis is recognized as the pathological basis of cardiovascular disease (CVD) and recent advances in basic science have shown that it should be considered as a chronic inflammatory process. Both elements of the innate and the adaptive immunity appear to be actively involved in atherogenesis. In fact, the pot...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2213oa

    authors: Rattazzi M,Faggin E,Bertipaglia B,Pauletto P

    更新日期:2005-01-01 00:00:00

  • Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report.

    abstract::Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Cases complicated with DAH often have active SLE with multi-organ involvement, especially lupus nephritis. We describe a rare case of DAH as the first presenting manifestation of SLE in the absence of lupus neph...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311411353

    authors: Al Rashidi A,Alajmi M,Hegazi MO

    更新日期:2011-12-01 00:00:00

  • The role of endothelial dysfunction in the pathogenesis of neuropsychiatric systemic lupus erythematosus.

    abstract::Neuropsychiatric manifestations of systemic lupus erythematosus are common and disabling yet their pathogenesis is poorly understood. We investigated the role of cerebrovascular endothelial dysfunction in systemic lupus erythematosus and its neuropsychiatric manifestations. Subjects with systemic lupus erythematosus w...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309359780

    authors: Davey R,Bamford J,Emery P

    更新日期:2010-06-01 00:00:00

  • Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?

    abstract::The aim of this study was to determine if the measurement of anti-beta2-glycoprotein I antibodies (abeta2-GPI) in serum levels contributes to the better characterization of the clinical situation of patients with antiphospholipid syndrome (APS). For this purpose abeta2-GPI of both isotypes was measured in 42 patients ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339900800604

    authors: Detkov,Gil-Aguado A,Lavilla P,Cuesta MV,Fontán G,Pascual-Salcedo D

    更新日期:1999-01-01 00:00:00

  • Nervous system lupus mimics limbic encephalitis.

    abstract::A 28-year-old woman with systemic lupus erythematosus (SLE) suffered recent onset fever, headache, encephalopathy followed by severe, repeated generalized seizures. Investigations revealed limbic encephalitis. Tests for Herpes simplex encephalitis and paraneoplastic encephalomyelitis were negative. High titers anti-ri...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920523

    authors: Stübgen JP

    更新日期:1998-01-01 00:00:00

  • Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.

    abstract::The complexity of the therapeutic approach in systemic lupus erythematosus (SLE) is increased by the large number of patients who do not respond to the first-line therapies and by relapses after initial clinical remission. In these patients, second-line drugs are often prescribed according to individual clinical decis...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309106174

    authors: Ramos-Casals M,Soto MJ,Cuadrado MJ,Khamashta MA

    更新日期:2009-08-01 00:00:00

  • Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China.

    abstract::Objective Genetic variants in FH (complement factor H) were reported to associate with susceptibility to systemic lupus erythematosus (SLE). This study proposed that the genetic defects of FH in the susceptibility and in the development of lupus nephritis might be different. Methods This study enrolled 334 lupus nephr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317702254

    authors: Tan M,Hao JB,Chu H,Wang FM,Song D,Zhu L,Yu F,Li YZ,Song Y,Zhao MH

    更新日期:2017-10-01 00:00:00

  • Osteoporosis: gender differences and similarities.

    abstract::Although osteoporosis has traditionally been considered a disease of women, men also incur substantial bone loss with aging, and elderly men have age-specific hip fracture incidence rates and vertebral fracture prevalence rates that are at least half those in women. Early postmenopausal bone loss (which results in the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339900800513

    authors: Khosla S,Melton LJ 3rd,Riggs BL

    更新日期:1999-01-01 00:00:00

  • Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id beta.

    abstract::We describe a human monoclonal antibody designated WRI 176 beta and a common idiotype that it carries. This antibody was derived from the spleen of a patient with SLE. WRI 176 is an IgM kappa monoclonal reacting with ssDNA, dsDNA, poly(dT) and it is likely that mAb WRI 176 beta is a representative of the so-called nat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300105

    authors: Blanco F,Longhurst C,Watts R,Kalsi J,Wiloch HW,Youinou P,Latchman DS,Isenberg DA

    更新日期:1994-02-01 00:00:00

  • Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.

    abstract::Mycophenolate mofetil (MMF) is effective in the treatment of patients with active systemic lupus erythematosus (SLE). We sought to evaluate its efficacy in reducing the number of disease flares in adults with SLE. For this retrospective study, all patients seen at our institution over a six year period, 1999-2005, wit...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308099242

    authors: Nannini C,Crowson CS,Matteson EL,Moder KG

    更新日期:2009-04-01 00:00:00

  • Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?

    abstract:OBJECTIVE:YB current affiliation: Department of Pediatrics, Hadassah-Hebrew University Medical Center, Mount Scopus, Israel YB and MJS contributed equally to the study and should be regarded as joint first authors on this manuscript. Antiphospholipid syndrome (APS) may present with thrombosis and persistently elevated ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314531842

    authors: Berkun Y,Simchen MJ,Strauss T,Menashcu S,Padeh S,Kenet G

    更新日期:2014-09-01 00:00:00

  • Antiphospholipid syndrome and tissue factor: a thrombotic couple.

    abstract::The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). Among the thrombogenic mechanisms proposed, it has been suggested that aPL can stimulate tissue factor (TF) expression by endothelial cells (ECs) and monocytes. Moreover, ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203306lu2276rr

    authors: López-Pedrera Ch,Buendía P,Aguirre MA,Velasco F,Cuadrado MJ

    更新日期:2006-01-01 00:00:00

  • Serum level of anti-α-enolase antibody in untreated systemic lupus erythematosus patients correlates with 24-hour urine protein and D-dimer.

    abstract::Objective The objective of this report is to evaluate the prevalence and clinico-serological correlations of anti-α-enolase antibody (Ab) in patients with systemic lupus erythematosus (SLE). Methods Thirty-two untreated patients with SLE and 20 age- and sex-matched healthy controls were evaluated by rheumatologic exam...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317721752

    authors: Li M,Li J,Wang J,Li Y,Yang P

    更新日期:2018-01-01 00:00:00

  • Vitamin D insufficiency in a large female SLE cohort.

    abstract::The objective of this study was to determine the vitamin D status and its relationship with disease and therapy features and with bone mineral density in women with systemic lupus erythematosus. Non-pregnant systemic lupus erythematosus women with dual-energy X-ray absorptiometry and vitamin D measurements performed b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345775

    authors: Toloza SM,Cole DE,Gladman DD,Ibañez D,Urowitz MB

    更新日期:2010-01-01 00:00:00

  • Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study.

    abstract:BACKGROUND:Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and life-threatening condition with poor prognosis in patients with antiphospholipid syndrome (APS). Pulmonary thromboendarterectomy (PTE) is the optimal surgical option for CTEPH. OBJECTIVES:This retrospective cohort study aimed to evaluate th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318810427

    authors: Li C,Zhao J,Liu S,Song W,Zhu J,Hua L,Wang Q,Li M,Zeng X,Zhao Y

    更新日期:2018-12-01 00:00:00

  • Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.

    abstract::Recent studies have revealed new populations of T/B cells, including central/effector memory, follicular T cells and CXCR3+ or CXCR4+ B cells. In the present study, changes in these populations of CD4+ T cells were examined on the basis of the expression of CD62L, CCR7 and CXCR5 in patients with systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307085246

    authors: Watanabe T,Suzuki J,Mitsuo A,Nakano S,Tamayama Y,Katagiri A,Amano H,Morimoto S,Tokano Y,Takasaki Y

    更新日期:2008-01-01 00:00:00

  • Risk of complications of ultrasound-guided renal biopsy for adult and pediatric patients with systemic lupus erythematosus.

    abstract::Objective The objective of this paper is to identify the risk of complications of real-time ultrasound-guided renal biopsy in adult and pediatric patients with systemic lupus erythematosus (SLE). Materials and methods This retrospective study examined outcomes of 296 renal biopsy procedures in 275 SLE patients. Imagin...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317751048

    authors: Sun YS,Sun IT,Wang HK,Yang AH,Tsai CY,Huang CJ,Huang DF,Lai CC

    更新日期:2018-04-01 00:00:00

  • Interleukin-2 and systemic lupus erythematosus--fifteen years later.

    abstract::Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder in which multiple immunologic abnormalities have been described. In this review, we thoroughly analyse the impaired T cell production of, and response to, interleukin-2 (IL-2) characteristic of patients with SLE. Since it was first reported, several...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920028

    authors: Crispin JC,Alcocer-Varela J

    更新日期:1998-01-01 00:00:00

  • Biochemical characterization of ADP-ribose polymer metabolism in SLE.

    abstract::The metabolism of poly(ADP-ribose) in peripheral blood mononuclear (PBM) cells was studied in 13 patients with systemic lupus erythematosus (SLE) and in 12 age and sex matched controls. Poly(ADP-ribose) polymerase activity was measured as the net accumulation of ADP-ribose polymers during the conversion of 32P-NAD to ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1177/096120339600500105

    authors: Chen HY,Pertusi RM,Kirkland JB,Rubin BR,Jacobson EL

    更新日期:1996-02-01 00:00:00

  • New immunosuppresor strategies in the treatment of murine lupus nephritis.

    abstract::Renal involvement in systemic lupus erythematosus is a common complication that significantly worsens morbidity and mortality. Although treatment with corticosteroids and cytotoxic drugs may be useful in many cases, morbidity associated with these drugs and the relapsing nature of the disease make it necessary to deve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306073136

    authors: Alperovich G,Rama I,Lloberas N,Franquesa M,Poveda R,Gomà M,Herrero-Fresneda I,Cruzado JM,Bolaños N,Carrera M,Grinyó JM,Torras J

    更新日期:2007-01-01 00:00:00

  • Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience.

    abstract:OBJECTIVE:To evaluate the occurrence of idiopathic intracranial hypertension (IIH) in patients with systemic lupus erythematosus (SLE) and to describe the manifestations, treatments and outcomes in these patients. METHODS:We reviewed the medical records of 1084 patients with SLE followed up from January 1997 to June 2...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311435267

    authors: Kim JM,Kwok SK,Ju JH,Kim HY,Park SH

    更新日期:2012-04-01 00:00:00

  • High-dose cyclophosphamide for severe systemic lupus erythematosus.

    abstract::Cytotoxic therapy is a cornerstone for patients with severe systemic lupus erythematosus (SLE). High-dose cyclophosphamide, 200 mg/kg, can induce a complete remission without the need for stem cell rescue in patients with autoimmune illnesses. Here we report on our first four patients treated for severe SLE with this ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203302lu229oa

    authors: Gladstone DE,Prestrud AA,Pradhan A,Styler MJ,Topolsky DL,Crilley PA,Hoch S,Huppert A,Brodsky I

    更新日期:2002-01-01 00:00:00

  • Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

    abstract:INTRODUCTION:High-mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316644331

    authors: Jog NR,Blanco I,Lee I,Putterman C,Caricchio R

    更新日期:2016-12-01 00:00:00

  • Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.

    abstract:OBJECTIVE:The objective of this paper is to examine some solid tumors incidence in patients with systemic lupus erythematosus (SLE) derived from population-based cohort studies by means of meta-analysis. METHODS:Relevant electronic databases were searched for studies characterizing the associated risk of overall malig...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析,评审

    doi:10.1177/0961203313520060

    authors: Ni J,Qiu LJ,Hu LF,Cen H,Zhang M,Wen PF,Wang XS,Pan HF,Ye DQ

    更新日期:2014-03-01 00:00:00

  • Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.

    abstract::Patients with antiphospholipid syndrome (APS) produce antiphospholipid antibodies (aPL) and develop vascular thrombosis that may occur in large or small vessels in the arterial or venous beds. On the other hand, many individuals produce aPL and yet never develop thrombotic events. Toll-like receptor 4 (TLR4) appears t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315603146

    authors: Laplante P,Fuentes R,Salem D,Subang R,Gillis MA,Hachem A,Farhat N,Qureshi ST,Fletcher CA,Roubey RA,Merhi Y,Thorin É,Levine JS,Mackman N,Rauch J

    更新日期:2016-02-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.

    abstract::The objective of this study was to assess the prevalence, clinical, histological and immunological characteristics, and the long-term outcome of polymyositis- (PM) and dermatomyositis- (DM) associated lung disease, and to define subgroups of lung-associated inflammatory myopathies. This retrospective study included 81...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2158oa

    authors: Selva-O'Callaghan A,Labrador-Horrillo M,Muñoz-Gall X,Martínez-Gomez X,Majó-Masferrer J,Solans-Laque R,Simeon-Aznar CP,Morell-Brotard F,Vilardell-Tarrés M

    更新日期:2005-01-01 00:00:00

  • Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus.

    abstract::To assess bladder function in systemic lupus erythematosus (SLE) patients with recurrent urinary tract infections (UTIs). A convenience sample of consecutive patients with SLE (American College of Rheumatology criteria), with recurrent UTIs (>/=3 events in the preceding 12 months), without history of central nervous s...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308093458

    authors: Duran-Barragan S,Ruvalcaba-Naranjo H,Rodriguez-Gutierrez L,Solano-Moreno H,Hernandez-Rios G,Sanchez-Ortiz A,Ramos-Remus C

    更新日期:2008-12-01 00:00:00

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice.

    abstract::The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB x NZWF1 (B/WF1) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease bega...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu483oa

    authors: Hasegawa K,Hayashi T

    更新日期:2003-01-01 00:00:00